Haemonetics (HAE) Accounts Payables (2010 - 2026)

Haemonetics' Accounts Payables history runs 17 years deep, the most recent figure standing at $51.1 million for Q1 2026.

• On a quarterly basis, Accounts Payables fell 23.8% year-over-year to $51.1 million in Q1 2026; TTM through Mar 2026 was $51.1 million, a 23.8% decrease from a year earlier, with the FY2026 full-year figure at $51.1 million, down 23.8% from the prior year.
• Accounts Payables climbed to $51.1 million in Q1 2026 per HAE's latest filing, from $48.7 million in the prior quarter.
• Across five years, Accounts Payables topped out at $80.2 million in Q3 2023 and bottomed at $46.0 million in Q2 2025.
• The 5-year median for Accounts Payables is $62.3 million (2024), against an average of $62.7 million.
• Across the five-year window, Accounts Payables surged 36.73% in 2022 and tumbled 40.19% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $63.8 million in 2022, then fell by 10.86% to $56.8 million in 2023, then increased by 10.81% to $63.0 million in 2024, then fell by 22.7% to $48.7 million in 2025, then increased by 4.85% to $51.1 million in 2026.
• Per Business Quant, the three latest HAE Accounts Payables figures stand at $51.1 million (Q1 2026), $48.7 million (Q4 2025), and $61.7 million (Q3 2025).